How to buy Molecular Templates stock (MTEM)

Molecular Templates is a biotechnology business based in the US. Molecular Templates shares (MTEM) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.16 – a decrease of 60% over the previous week. Molecular Templates employs 62 staff and has a trailing 12-month revenue of around $25.5 million.

Our top picks for where to buy Molecular Templates stock

Buy Molecular Templates stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Molecular Templates stock price (NASDAQ: MTEM)

Use our graph to track the performance of MTEM stocks over time.

Molecular Templates shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$0.16
52-week range	$0.30 - $4.12
50-day moving average more info button	$0.53
200-day moving average more info button	$1.31
Wall St. target price	$18.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-3.05

Is it a good time to buy Molecular Templates stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Molecular Templates price performance over time

Historical closes compared with the close of $0.35 from 2024-12-19

1 week (2024-12-13)	-12.50%
1 month (2024-11-21)	-7.89%
3 months (2024-09-20)	-74.07%
6 months (2024-06-21)	-67.89%

1 year (2023-12-21)	-90.57%
2 years (2022-12-21)	-93.61%
3 years (2021-12-21)	55.05
5 years (2019-12-20)	187.95

Molecular Templates financials

Revenue TTM	$25.5 million
Gross profit TTM	$-45,968,000
Return on assets TTM	-37.88%
Return on equity TTM	-929.14%
Profit margin	-61.35%
Book value	$1.08
Market Capitalization more info button	$2.3 million

TTM: trailing 12 months

Molecular Templates share dividends

We're not expecting Molecular Templates to pay a dividend over the next 12 months.

Have Molecular Templates's shares ever split?

Molecular Templates's shares were split on a 1:15 basis on 13 August 2023 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Molecular Templates shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Molecular Templates shares which in turn could have impacted Molecular Templates's share price.

Molecular Templates share price volatility

Over the last 12 months, Molecular Templates's shares have ranged in value from as little as $0.295 up to $4.12. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Molecular Templates's is 1.219. This would suggest that Molecular Templates's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Molecular Templates overview

Molecular Templates, Inc. , a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

Frequently asked questions

What percentage of Molecular Templates is owned by insiders or institutions?
Currently 3.961% of Molecular Templates shares are held by insiders and 35.006% by institutions. How many people work for Molecular Templates?
Latest data suggests 62 work at Molecular Templates. When does the fiscal year end for Molecular Templates?
Molecular Templates's fiscal year ends in December. Where is Molecular Templates based?
Molecular Templates's address is: 9301 Amberglen Boulevard, Austin, TX, United States, 78729 What is Molecular Templates's ISIN number?
Molecular Templates's international securities identification number is: US6085501095 What is Molecular Templates's CUSIP number?
Molecular Templates's Committee on Uniform Securities Identification Procedures number is: 885807107